New drink aims to help malnourished patients – but will they like it?
NCT ID NCT07452523
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new oral nutritional supplement called AYMES SWIFT in 40 adults who are malnourished or at risk of malnutrition. Participants will take the supplement for 7 days, and researchers will measure how well they tolerate it (digestive comfort) and how much they like it (taste, smell, texture). The goal is to see if this supplement is a good option for people who need extra nutrition due to illness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AYMES SWIFT oral nutritional supplement (a food for special medical purposes)
- What this could lead to
- If successful, this could provide a well-tolerated and acceptable nutritional supplement for people with or at risk of disease-related malnutrition.
- What could go wrong
- This is a small, early-stage study focused on tolerance and acceptability, not on treating the underlying disease. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISEASE RELATED MALNUTRITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Preston Hill Surgery
Harrow, HA3 9SN, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.